1. Home
  2. NXPL vs GDTC Comparison

NXPL vs GDTC Comparison

Compare NXPL & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXPL
  • GDTC
  • Stock Information
  • Founded
  • NXPL 1997
  • GDTC 2018
  • Country
  • NXPL United States
  • GDTC Singapore
  • Employees
  • NXPL N/A
  • GDTC N/A
  • Industry
  • NXPL Telecommunications Equipment
  • GDTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • NXPL Telecommunications
  • GDTC Health Care
  • Exchange
  • NXPL Nasdaq
  • GDTC Nasdaq
  • Market Cap
  • NXPL 32.5M
  • GDTC 29.4M
  • IPO Year
  • NXPL N/A
  • GDTC 2023
  • Fundamental
  • Price
  • NXPL $1.04
  • GDTC $2.89
  • Analyst Decision
  • NXPL
  • GDTC Buy
  • Analyst Count
  • NXPL 0
  • GDTC 1
  • Target Price
  • NXPL N/A
  • GDTC $5.00
  • AVG Volume (30 Days)
  • NXPL 204.1K
  • GDTC 56.5K
  • Earning Date
  • NXPL 11-14-2024
  • GDTC 01-01-0001
  • Dividend Yield
  • NXPL N/A
  • GDTC N/A
  • EPS Growth
  • NXPL N/A
  • GDTC N/A
  • EPS
  • NXPL N/A
  • GDTC N/A
  • Revenue
  • NXPL $66,482,000.00
  • GDTC $330,254.00
  • Revenue This Year
  • NXPL N/A
  • GDTC $14.71
  • Revenue Next Year
  • NXPL N/A
  • GDTC N/A
  • P/E Ratio
  • NXPL N/A
  • GDTC N/A
  • Revenue Growth
  • NXPL 179.89
  • GDTC N/A
  • 52 Week Low
  • NXPL $0.71
  • GDTC $1.20
  • 52 Week High
  • NXPL $2.68
  • GDTC $4.05
  • Technical
  • Relative Strength Index (RSI)
  • NXPL 45.75
  • GDTC 58.11
  • Support Level
  • NXPL $0.95
  • GDTC $2.35
  • Resistance Level
  • NXPL $1.35
  • GDTC $2.94
  • Average True Range (ATR)
  • NXPL 0.10
  • GDTC 0.27
  • MACD
  • NXPL -0.02
  • GDTC 0.05
  • Stochastic Oscillator
  • NXPL 22.50
  • GDTC 93.15

About NXPL NextPlat Corp

NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: